summary: This open-label trial evaluates the effect of levetiracetam (LEV) to treat cerebellar tremor in MS patients. The authors conclude that LEV could be useful for the management of cerebellar tremor in MS and the good tolerability makes it easy to test. LEV long-term efficacy should be confirmed in extended studies.

authors: Striano P, Coppola A, Vacca G, Zara F, Brescia Morra V, Orefice G, Striano S.

source: J Neurol. 2006 May 12; [Epub ahead of print]

weblink: click here

category: Clinical Trials and Therapeutics

related research news: click here

glossary: